US Stock MarketDetailed Quotes

OGN Organon & Co

Watchlist
  • 14.910
  • -0.130-0.86%
Close Feb 28 16:00 ET
  • 14.899
  • -0.011-0.07%
Post 18:58 ET
3.84BMarket Cap4.48P/E (TTM)

About Organon & Co Company

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

Company Profile

SymbolOGN
Company NameOrganon & Co
Listing DateMay 14, 2021
Founded2020
CEOMr. Kevin Ali
MarketNYSE
Employees10000
Fiscal Year Ends12-31
Address30 Hudson Street,33rd floor
CityJersey City
ProvinceNew Jersey
CountryUnited States of America
Zip Code07302
Phone1-551-430-6900
Websitehttp://www.organon.com

Company Executives

  • Name
  • Position
  • Salary
  • Kevin Ali
  • Chief Executive Officer and Director
  • 14.83M
  • Aaron Falcione
  • Executive Vice President and Chief Human Resources Officer
  • --
  • Dr. Juan Camilo Arjona Ferreira, M.D.
  • Executive Vice President, Head of Research and Development and Chief Medical Officer
  • --
  • Rachel A. Stahler
  • Executive Vice President and Chief Information Officer
  • --
  • Matthew M. Walsh
  • Executive Vice President and Chief Financial Officer
  • 5.21M
  • Vittorio Nisita
  • Executive Vice President and Head of Global Business Services
  • --
  • Joseph T. Morrissey, Jr
  • Executive Vice President and Head of Manufacturing and Supply
  • 3.74M
  • Kirke Weaver
  • Executive Vice President, General Counsel and Corporate Secretary
  • 3.19M
  • Carrie S. Cox
  • Chairman of the Board
  • 450.00K
  • Robert A. Essner
  • Independent Director
  • 335.00K
  • Dr. Alan Ezekowitz, D.Phil.,MB.Ch.B.
  • Independent Director
  • 330.00K
  • Cynthia M. Patton
  • Independent Director
  • 330.00K
  • Rochelle B. Lazarus
  • Independent Director
  • 320.00K
  • Grace Puma Whiteford
  • Independent Director
  • 320.00K
  • Dr. Phillip Ozuah, M.D.,PhD
  • Independent Director
  • 320.00K
  • Shalini Sharp
  • Independent Director
  • 345.00K
  • Deborah R. Leone
  • Independent Director
  • 330.00K
  • Dr. Helene D. Gayle, M.D.
  • Independent Director
  • 320.00K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
LINTEX
920106
+30.00%
LINGOOD
833284
+29.98%
NTGEC
870436
+29.98%
4
CG MED EQUIP.
838810
+29.97%
5
Jiayu Holding
300117
+20.48%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!